[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363138-105":59,"doc-detail-363138-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ccr7-immune-cell-receptor-expression-in-inflammatory-breast-cancer","CCR7 immune cell receptor expression in inflammatory breast cancer","","Inflammatory breast cancer (IBC) features tumor emboli that congest dermal lymphovascular spaces. The study quantifies CCR7 gene expression in IBC cell lines and patient tissues, using the World IBC Consortium Database, and correlates it with CCR7 protein levels in cell lines and postneoadjuvant mastectomy samples. Tissue microarrays were evaluated by membrane completeness, tumor positivity, and staining intensity. CCR7 is strongly expressed in IBC, especially in HER2-positive and basal-like subtypes, suggesting potential for antibody-based targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ccr7-immune-cell-receptor-expression-in-inflammatory-breast-cancer/363138/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ccr7-immune-cell-receptor-expression-in-inflammatory-breast-cancer/363138.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How is CCR7 expression measured in inflammatory breast cancer samples?","Question",{"text":112,"@type":113},"CCR7 gene expression is quantified using the World IBC Consortium Database, and protein expression is assessed in cell lines and IBC mastectomy samples after neoadjuvant therapy. Tissue microarrays are scored by membrane staining pattern, percent tumor positivity, and staining intensity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the study find about CCR7 levels in IBC compared with non-IBC?",{"text":117,"@type":113},"Among 137 IBC and 252 non-IBC patient samples, CCR7 gene expression is significantly higher in IBC than in non-IBC (p = 0.0007).",{"name":119,"@type":110,"acceptedAnswer":120},"Which IBC subtypes show higher CCR7 gene expression and what is the potential impact?",{"text":121,"@type":113},"Within IBC samples, higher CCR7 gene expression is associated with HER2+ (p = 0.0002), basal (p = 0.0161), and ER-IBC patients (p = 0.010). Given its high prevalence, CCR7 may serve as a potential target for antibody-based drug design in future studies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363138,1790292687,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCCR7 immune cell receptor expression in inflammatory breast cancer  \nJennifer H. Chen1,15, Wintana Balema2,3,4,15, Savitri Krishnamurthy7, Alison N. Lawrence3, Natalie W. Fowlkes6, Richard A. Larson3,4, Surbhi Shivhare4, Caren Sanchez3,4,  \nMegan M. Rodriguez3, Jangsoon Lee8, Emilly S. Villodre4,13, Bisrat G. Debeb2,4,13, Naoto T. Ueno8, Steve Van Laere9, Francois Bertucci10, Hyunwoo Cho11, Erik P. Sulman12, Bora Lim4,13 & Wendy A. Woodward2,4,5,14􀀍  \nInflammatory breast cancer (IBC) is characterized by congestion of dermal lymphovascular spaces by tumor emboli. We characterized expression ofCCR7, a lymphocyte homing chemokine receptor, in IBC cell lines and patient tissues. CCR7 gene expression was quantified using World IBC Consortium Database and correlated with protein expression in cell lines and IBC mastectomy samples postneoadjuvant therapy. CCR7 expression on tissue microarray (TMA) was scored by staining pattern (complete vs. incomplete membranous), percent tumor stained, and staining intensity. CCR7 was highly expressed in IBC cell lines and a previously validated preclinical mouse model. Among 137 IBC and 252 non-IBC patient samples, CCR7 gene expression was significantly higher in IBC compared to non-IBC (p = 0.0007). Within IBC samples, gene expression was higher in HER2+ (p = 0.0002), basal (p = 0.0161), and ER-IBC patients (p = 0.010). Of the 24 IBCTMAs, almost all were CCR7 positive (23, 95.8%), with 15 (62.5%) demonstrating completely membranous expression. CCR7 is highly expressed in IBC cell lines and patient tumor samples, with preferential expression in HER2-positive and basal-like IBC subtypes. Given its high prevalence, CCR7 may serve as a potential target for antibody-based drug design in future IBC studies.  \nKeywords Inflammatory breast cancer, CCR7, CCL21, RNA seq, single cell breast atlas  \nInflammatory breast cancer (IBC) is a rare and aggressive breast cancer subtype characterized by congestion of lymphovascular spaces by tumor emboli.1 Clinically, occlusion of dermal lymphatics results in downstream symptoms of rapid onset breast discoloration, most often as erythema, edema, skin thickening, and peaud’orange appearance.1 While prognosis has improved with contemporary trimodality therapy, overall survival rates for IBC still lag behind that for non-IBC disease.2,3 Specific to IBC and contributory to its aggressive nature include higher proliferation rates, increased tumor angiogenesis and lymphangiogenesis, and early metastasis.4–7 Studies suggest higher expression of chemokine receptors, such as C-C motif chemokine receptor 7 (CCR7), may contribute to more aggressive phenotypes and mediate nodal metastases in invasive breast cancer.8–12 CCR7 is a G-protein-coupled cell receptor (GPCR) on immune cells that mediates trafficking towards lymphatic  \n1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2MD Anderson UT Health Houston Graduate School of Biomedical Sciences, Houston,TX, USA. 3Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4The Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 5Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 6Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.  \n7Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 8University of Hawaiʻi Cancer Center, Honolulu, HI, USA. 9Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium. 10Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France. 11Applied Bioinformatic","cbCaitFFBcFPAb4U","https://ap.wps.com/l/cbCaitFFBcFPAb4U","pdf",2081511,"English","# Background and clinical significance\n## Inflammatory breast cancer characteristics\n## CCR7 biology and prior evidence\n# Study design and methods\n## CCR7 gene expression quantification\n## Protein validation in cell lines and tissues\n## Tissue microarray scoring\n# Results\n## CCR7 expression in IBC vs non-IBC\n## Subtype associations within IBC\n## Prevalence across tissue microarrays\n# Implications\n## Therapeutic targeting and future study directions","[{\"question\":\"How is CCR7 expression measured in inflammatory breast cancer samples?\",\"answer\":\"CCR7 gene expression is quantified using the World IBC Consortium Database, and protein expression is assessed in cell lines and IBC mastectomy samples after neoadjuvant therapy. Tissue microarrays are scored by membrane staining pattern, percent tumor positivity, and staining intensity.\"},{\"question\":\"What does the study find about CCR7 levels in IBC compared with non-IBC?\",\"answer\":\"Among 137 IBC and 252 non-IBC patient samples, CCR7 gene expression is significantly higher in IBC than in non-IBC (p = 0.0007).\"},{\"question\":\"Which IBC subtypes show higher CCR7 gene expression and what is the potential impact?\",\"answer\":\"Within IBC samples, higher CCR7 gene expression is associated with HER2+ (p = 0.0002), basal (p = 0.0161), and ER-IBC patients (p = 0.010). Given its high prevalence, CCR7 may serve as a potential target for antibody-based drug design in future studies.\"}]","CCR7 immune cell receptor expression in inflammatory breast cancer | PDF",1790150134,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d498a061901c1218518e171863433350.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca7bc20c368053b6f46e25d24322383d.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2751af48a5f269b55ab8c5ff880f7b5a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/125e992983d8737ee314e4a9ac247e52.webp",980,1287]